Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes, and tumor of head and neck cancer patients
- PMID: 3409231
Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes, and tumor of head and neck cancer patients
Abstract
This study evaluated peripheral blood lymphocyte and lymph node lymphocyte natural killer (NK) cell activity in 22 patients with head and neck squamous cell carcinoma and eight patients undergoing surgery for nonmalignant conditions who served as controls. A novel mixed-model analysis of variance was used to analyze the results because of the inherent difficulties in data interpretation among heterogeneous groups when several concurrent variables impinge upon the results. The peripheral blood lymphocyte NK activity of cancer patients was significantly less than controls. In contrast, lytic activity from uninvolved draining lymph nodes of cancer patients was comparable to the activity of control nodes. However, if the node contained a small focus of metastatic tumor, NK activity was significantly diminished relative to uninvolved nodes from cancer patients or to control nodes. The mixed-model analysis of variance was particularly helpful in confirming this finding. Finally, NK lysis by tumor-infiltrating lymphocytes, purified from grossly metastatic nodes, was severely depressed. These data indicate that a spectrum of NK suppression exists in draining lymph nodes of head and neck squamous cell carcinoma patients, and that the level of activity depends upon the degree of nodal tumor involvement.
Similar articles
-
Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.Nat Immun Cell Growth Regul. 1985;4(6):315-27. Nat Immun Cell Growth Regul. 1985. PMID: 4088287
-
Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.Clin Immunol. 2002 Jan;102(1):37-47. doi: 10.1006/clim.2001.5130. Clin Immunol. 2002. PMID: 11781066
-
Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.Cancer Res. 1991 Aug 1;51(15):3891-9. Cancer Res. 1991. PMID: 1677310
-
The relevance of tumor draining lymph nodes in cancer.Surg Gynecol Obstet. 1992 Jun;174(6):533-40. Surg Gynecol Obstet. 1992. PMID: 1595033 Review.
-
Natural killer cell activity in patients with carcinoma of the larynx and hypopharynx.Laryngoscope. 1985 Nov;95(11):1391-400. doi: 10.1288/00005537-198511000-00020. Laryngoscope. 1985. PMID: 3903404 Review.
Cited by
-
Functional Assessment for Clinical Use of Serum-Free Adapted NK-92 Cells.Cancers (Basel). 2019 Jan 10;11(1):69. doi: 10.3390/cancers11010069. Cancers (Basel). 2019. PMID: 30634595 Free PMC article.
-
Interferons and other cytokines in head and neck cancer.Med Oncol. 1995 Mar;12(1):23-33. doi: 10.1007/BF01571405. Med Oncol. 1995. PMID: 8542243 Review.
-
Suppression of natural killer-cell and dendritic-cell apoptotic tumoricidal activity in patients with head and neck cancer.Head Neck. 2013 Mar;35(3):388-98. doi: 10.1002/hed.22968. Epub 2012 Apr 5. Head Neck. 2013. PMID: 22488918 Free PMC article.
-
Biologic markers, cellular differentiation, and metastatic head and neck cancer.Eur Arch Otorhinolaryngol. 1993;250(8):424-8. doi: 10.1007/BF00181082. Eur Arch Otorhinolaryngol. 1993. PMID: 8129918 Review.
-
Investigational EGFR-targeted therapy in head and neck squamous cell carcinoma.Expert Opin Investig Drugs. 2010 Jun;19(6):709-22. doi: 10.1517/13543781003769844. Expert Opin Investig Drugs. 2010. PMID: 20415598 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical